trending Market Intelligence /marketintelligence/en/news-insights/trending/OA-ANgzVCBPD3QsNo0sLHw2 content esgSubNav
In This List

Medibio chairman to step down; interim named

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Medibio chairman to step down; interim named

Medibio Ltd. said Christopher Indermaur is stepping down as nonexecutive chairman of the company, effective Dec. 31, to focus on other business interests.

Peter Carlisle, the Australian medical technology company's vice chairman, will act as interim chairman from Dec. 31 until a permanent chairman is elected.

Meanwhile, Claude Solitario was also appointed nonexecutive director of the company to fill the vacated board seat, also effective Dec. 31. Solitario is a founding shareholder of Medibio.

Medibio develops diagnostic systems for mental health illnesses in Australia and the U.S.